🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07721766
Recruiting Not applicable

Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training

NCT07721766 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2026-05-04
Last updated
2026-07-23

Condition(s) studied

Healthy VolunteersMuscle HypertrophyGlycolysisModerately Trainend

Investigational drug(s) / intervention(s)

Hypertrophy-focused Resistance Training

Hypertrophy-focused Resistance Training: Standardized training consisting of twice-weekly supervised sessions for 8 weeks. Each session includes 4 sets of 8-12 repetitions of leg press (or Smith-machine squat) and leg extensions. Training intensity progresses from an RPE of 6 to voluntary muscular failure starting from week three.

Study summary

The HyperLa study investigates whether a person's "glycolyticness"-the efficiency with which their body uses glycolysis for energy-can predict how much their muscles will grow (hypertrophy) in response to resistance training. Participants will undergo a specialized "vLapeak" test, which measures the maximal rate of lactate accumulation during a 10-second all-out cycling sprint, to determine their individual glycolytic power. Following this initial assessment, participants will complete eight weeks of standardized, twice-weekly resistance training focused on the lower body. The study aims to determine if individuals with higher initial vLapeak values experience greater increases in muscle size compared to those with lower values. This research may help explain why people respond differently to exercise and support the development of personalized training programs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
39 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Body Mass Index (BMI) between 20-29 kg/m2 * No structured resistance training performed in the last twelve months. * Maximum of four sessions per week of recreational or low-to-moderate aerobic endurance activity. * No history of competitive strength or physique sports. Exclusion Criteria: * Diagnosed cardiovascular, pulmonary, metabolic, neuromuscular, or orthopaedic disease that contraindicates exercise. * Positive response to any question on the PAR-Q 2025 questionnaire. * Current use of anabolic steroids, creatine, or other substances known to strongly influence muscle hypertrophy. * Regular engagement in shift work. * Women who are pregnant or breastfeeding.

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
University of Jyväskylä, Faculty of Sport and Health Sciences Jyväskylä Central Finland Recruiting
Technical University of Munich, TUM School of Medicine and Health München Bavaria Recruiting
DLR Cologne, Department of Metabolism and Human Performance Cologne North Rhine-Westphalia Recruiting
iST University of Applied Sciences Düsseldorf North Rhine-Westphalia Recruiting
TU Chemnitz, Sports Medicine and Exercise Therapy Chemnitz Saxony Recruiting
Institute for Applied Training Science (IAT) Leipzig Leipzig Saxony Recruiting
University of Limerick, Department of Physical Education and Sport Sciences (PESS) Limerick Limerick Recruiting
Universidad Politécnica de Madrid, Facultad de Ciencias de la Actividad Física y del Deporte (INEF) Madrid Madrid Recruiting

More Technical University of Munich trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07721766 on ClinicalTrials.gov ↗ ← All trials in Germany